Cargando…

Prognostic significance of interleukin-17A-producing colorectal tumour antigen-specific T cells

BACKGROUND: The T cell cytokine profile is a key prognostic indicator of post-surgical outcome for colorectal cancer (CRC). Whilst T(H)1 (IFN-γ(+)) cell-mediated responses generated in CRC are well documented and are associated with improved survival, antigen-specific T(H)17 (IL-17A(+)) responses ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Thomson, Amanda, Bento, Diana F. Costa, Scurr, Martin J., Smart, Kathryn, Somerville, Michelle S., Keita, Åsa V., Gallimore, Awen, Godkin, Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8076199/
https://www.ncbi.nlm.nih.gov/pubmed/33674735
http://dx.doi.org/10.1038/s41416-021-01283-3
_version_ 1783684646308937728
author Thomson, Amanda
Bento, Diana F. Costa
Scurr, Martin J.
Smart, Kathryn
Somerville, Michelle S.
Keita, Åsa V.
Gallimore, Awen
Godkin, Andrew
author_facet Thomson, Amanda
Bento, Diana F. Costa
Scurr, Martin J.
Smart, Kathryn
Somerville, Michelle S.
Keita, Åsa V.
Gallimore, Awen
Godkin, Andrew
author_sort Thomson, Amanda
collection PubMed
description BACKGROUND: The T cell cytokine profile is a key prognostic indicator of post-surgical outcome for colorectal cancer (CRC). Whilst T(H)1 (IFN-γ(+)) cell-mediated responses generated in CRC are well documented and are associated with improved survival, antigen-specific T(H)17 (IL-17A(+)) responses have not been similarly measured. METHODS: We sought to determine the cytokine profile of circulating tumour antigen-(5T4/CEA) specific T cells of 34 CRC patients to address whether antigen-specific IL-17A responses were detectable and whether these were distinct to IFN-γ responses. RESULTS: As with IFN-γ-producing T cells, anti-5T4/CEA T(H)17 responses were detectable predominantly in early stage (TNM I/II) CRC patients. Moreover, whilst IL-17A was always produced in association with IFN-γ, this release was mainly from two distinct T cell populations rather than by ‘dual producing’ T cells. Patients mounting both tumour-specific T(H)1(+)/T(H)17(+) responses exhibited prolonged relapse-free survival. CONCLUSIONS: Tumour antigen-specific T(H)17 responses play a beneficial role in preventing post-operative colorectal tumour recurrence.
format Online
Article
Text
id pubmed-8076199
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-80761992021-05-05 Prognostic significance of interleukin-17A-producing colorectal tumour antigen-specific T cells Thomson, Amanda Bento, Diana F. Costa Scurr, Martin J. Smart, Kathryn Somerville, Michelle S. Keita, Åsa V. Gallimore, Awen Godkin, Andrew Br J Cancer Article BACKGROUND: The T cell cytokine profile is a key prognostic indicator of post-surgical outcome for colorectal cancer (CRC). Whilst T(H)1 (IFN-γ(+)) cell-mediated responses generated in CRC are well documented and are associated with improved survival, antigen-specific T(H)17 (IL-17A(+)) responses have not been similarly measured. METHODS: We sought to determine the cytokine profile of circulating tumour antigen-(5T4/CEA) specific T cells of 34 CRC patients to address whether antigen-specific IL-17A responses were detectable and whether these were distinct to IFN-γ responses. RESULTS: As with IFN-γ-producing T cells, anti-5T4/CEA T(H)17 responses were detectable predominantly in early stage (TNM I/II) CRC patients. Moreover, whilst IL-17A was always produced in association with IFN-γ, this release was mainly from two distinct T cell populations rather than by ‘dual producing’ T cells. Patients mounting both tumour-specific T(H)1(+)/T(H)17(+) responses exhibited prolonged relapse-free survival. CONCLUSIONS: Tumour antigen-specific T(H)17 responses play a beneficial role in preventing post-operative colorectal tumour recurrence. Nature Publishing Group UK 2021-03-05 2021-04-27 /pmc/articles/PMC8076199/ /pubmed/33674735 http://dx.doi.org/10.1038/s41416-021-01283-3 Text en © Crown 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Thomson, Amanda
Bento, Diana F. Costa
Scurr, Martin J.
Smart, Kathryn
Somerville, Michelle S.
Keita, Åsa V.
Gallimore, Awen
Godkin, Andrew
Prognostic significance of interleukin-17A-producing colorectal tumour antigen-specific T cells
title Prognostic significance of interleukin-17A-producing colorectal tumour antigen-specific T cells
title_full Prognostic significance of interleukin-17A-producing colorectal tumour antigen-specific T cells
title_fullStr Prognostic significance of interleukin-17A-producing colorectal tumour antigen-specific T cells
title_full_unstemmed Prognostic significance of interleukin-17A-producing colorectal tumour antigen-specific T cells
title_short Prognostic significance of interleukin-17A-producing colorectal tumour antigen-specific T cells
title_sort prognostic significance of interleukin-17a-producing colorectal tumour antigen-specific t cells
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8076199/
https://www.ncbi.nlm.nih.gov/pubmed/33674735
http://dx.doi.org/10.1038/s41416-021-01283-3
work_keys_str_mv AT thomsonamanda prognosticsignificanceofinterleukin17aproducingcolorectaltumourantigenspecifictcells
AT bentodianafcosta prognosticsignificanceofinterleukin17aproducingcolorectaltumourantigenspecifictcells
AT scurrmartinj prognosticsignificanceofinterleukin17aproducingcolorectaltumourantigenspecifictcells
AT smartkathryn prognosticsignificanceofinterleukin17aproducingcolorectaltumourantigenspecifictcells
AT somervillemichelles prognosticsignificanceofinterleukin17aproducingcolorectaltumourantigenspecifictcells
AT keitaasav prognosticsignificanceofinterleukin17aproducingcolorectaltumourantigenspecifictcells
AT gallimoreawen prognosticsignificanceofinterleukin17aproducingcolorectaltumourantigenspecifictcells
AT godkinandrew prognosticsignificanceofinterleukin17aproducingcolorectaltumourantigenspecifictcells